Promore Pharma: LL-37 cleared for phase IIb start
Research Note
2018-07-03
09:05
Promore announced today that the Swedish MPA has approved their phase IIb study and Promore can now start recruiting and treating patients.
MS
Mathias Spinnars
Disclosures and disclaimers